A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).
作者信息
Cherny N I, Sullivan R, Dafni U, Kerst J M, Sobrero A, Zielinski C, de Vries E G E, Piccart M J
出版信息
Ann Oncol. 2017 Nov 1;28(11):2901-2905. doi: 10.1093/annonc/mdw258.
PMID:27604385
Abstract
摘要
Zotero 插件